Balyasny Asset Management LLC Novartis Ag Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $1.99 Million - $2.31 Million	21,496 Added 175.13%	33,770 $3.6 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $686,706 - $781,851	7,208 Added 142.28%	12,274 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $106,202 - $116,872	1,151 Added 29.4%	5,066 $511,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $370,867 - $411,583	3,915 New	3,915 $398,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $10.3 Million - $11.7 Million	-129,088 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $10.3 Million - $11.4 Million	129,088 New	129,088 $11.3 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $25.3 Million - $29.8 Million	-303,004 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $23.4 Million - $28.3 Million	299,343 Added 8176.54%	303,004 $28.6 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $17.5 Million - $21.5 Million	-231,521 Reduced 98.44%	3,661 $334,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $16 Million - $17.8 Million	-217,599 Reduced 48.06%	235,182 $20.2 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $6.74 Million - $7.8 Million	100,695 Added 28.6%	452,781 $39 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $1.09 Million - $1.23 Million	16,799 Added 5.01%	352,086 $26.6 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $17.5 Million - $20.9 Million	248,605 Added 286.8%	335,287 $27.1 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $10.6 Million - $11.4 Million	-146,255 Reduced 62.79%	86,682 $7.28 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $17.3 Million - $18 Million	232,937	232,937 $20 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account